A carregar...
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
ABSTRACT: BACKGROUND: Monoclonal antibodies have become attractive clinical anti-cancer drugs in the last 3 decades due to their targeting specificity and suitable pharmacokinetic properties. Mesothelin is a tumor-associated antigen with limited expression in normal tissues. It is frequently over-ex...
Na minha lista:
| Publicado no: | Clin Cancer Drugs |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080863/ https://ncbi.nlm.nih.gov/pubmed/27853672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/2212697X03666160218215744 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|